Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-Alcoholic Steatohepatitis (NASH) and Organokines: What Is Now and What Will Be in the Future
João Paulo Margiotti dos Santos, Mariana Canevari de Maio, Monike Alves Lemes, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 1, pp. 498-498
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

The role of hepatokines in NAFLD
Norbert Stefan, Fritz Schick, Andreas L. Birkenfeld, et al.
Cell Metabolism (2023) Vol. 35, Iss. 2, pp. 236-252
Open Access | Times Cited: 131
The Effects of Probiotics, Prebiotics and Synbiotics in Non-Alcoholic Fat Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Systematic Review
Rodrigo Zamignan Carpi, Sandra Maria Barbalho, Kátia Portero Sloan, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8805-8805
Open Access | Times Cited: 86
Aging, oxidative stress and degenerative diseases: mechanisms, complications and emerging therapeutic strategies
Mani Raj Chaudhary, Sakshi Chaudhary, Yogita Sharma, et al.
Biogerontology (2023) Vol. 24, Iss. 5, pp. 609-662
Closed Access | Times Cited: 69
Time to Consider the “Exposome Hypothesis” in the Development of the Obesity Pandemic
Victoria Catalán, Icíar Avilés-Olmos, Amaia Rodrı́guez, et al.
Nutrients (2022) Vol. 14, Iss. 8, pp. 1597-1597
Open Access | Times Cited: 66
Glycolipid Metabolic Disorders, Metainflammation, Oxidative Stress, and Cardiovascular Diseases: Unraveling Pathways
Enzo Pereira de Lima, Renato Cesar Moretti, Karina Torres Pomini, et al.
Biology (2024) Vol. 13, Iss. 7, pp. 519-519
Open Access | Times Cited: 17
AdipoRon’s Impact on Alzheimer’s Disease—A Systematic Review and Meta-Analysis
Sandra Maria Barbalho, Lucas Fornari Laurindo, Bárbara de Oliveira Zanuso, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 484-484
Open Access | Times Cited: 1
Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets
Yinshuang Chen, Weipeng Wang, Maria P. Morgan, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 26
Endpoints in NASH Clinical Trials: Are We Blind in One Eye?
Amedeo Lonardo, Stefano Ballestri, Alessandro Mantovani, et al.
Metabolites (2024) Vol. 14, Iss. 1, pp. 40-40
Open Access | Times Cited: 10
Underlying Mechanisms behind the Brain–Gut–Liver Axis and Metabolic-Associated Fatty Liver Disease (MAFLD): An Update
Júlia Pauli De Cól, Enzo Pereira de Lima, Fernanda Moris Pompeu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3694-3694
Open Access | Times Cited: 10
Resmetirom's approval: Highlighting the need for comprehensive approaches in NASH therapeutics
Salah Abdalrazak Alshehade
Clinics and Research in Hepatology and Gastroenterology (2024) Vol. 48, Iss. 7, pp. 102377-102377
Closed Access | Times Cited: 9
Organokines, Sarcopenia, and Metabolic Repercussions: The Vicious Cycle and the Interplay with Exercise
Giulia Minniti, Letícia Maria Pescinini-Salzedas, Guilherme Almeida dos Santos Minniti, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13452-13452
Open Access | Times Cited: 31
Organokines in COVID-19: A Systematic Review
Sandra Maria Barbalho, Giulia Minniti, Vitor Fernando Bordin Miola, et al.
Cells (2023) Vol. 12, Iss. 10, pp. 1349-1349
Open Access | Times Cited: 15
AdipoRon and ADP355, adiponectin receptor agonists, in Metabolic-associated Fatty Liver Disease (MAFLD) and Nonalcoholic Steatohepatitis (NASH): A systematic review
Sandra Maria Barbalho, Nahúm Méndez‐Sánchez, Lucas Fornari Laurindo
Biochemical Pharmacology (2023) Vol. 218, pp. 115871-115871
Closed Access | Times Cited: 15
Metabolic-Associated Fatty Liver Disease: The Influence of Oxidative Stress, Inflammation, Mitochondrial Dysfunctions, and the Role of Polyphenols
Raissa Bulaty Tauil, Paula Takano Golono, Enzo Pereira de Lima, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1354-1354
Open Access | Times Cited: 4
Organokines in Rheumatoid Arthritis: A Critical Review
Lucas Fornari Laurindo, Mariana Canevari de Maio, Sandra Maria Barbalho, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6193-6193
Open Access | Times Cited: 20
The regulatory role of metabolic organ-secreted factors in the nonalcoholic fatty liver disease and cardiovascular disease
Qin Li, Junru Wu, Xuejing Sun, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 11
Peripheral and central macrophages in obesity
Sayani Mukherjee, Silje Skrede, Martha E. Haugstøyl, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 11
The Pan-liver Network Theory
Yaxing Zhang, Xian-Ming Fang
The Chinese Journal of Physiology (2023) Vol. 66, Iss. 6, pp. 401-436
Open Access | Times Cited: 10
Osteokines in Nonalcoholic Fatty Liver Disease
Ilias D. Vachliotis, Athanasios D. Anastasilakis, Vasileios Rafailidis, et al.
Current Obesity Reports (2024)
Closed Access | Times Cited: 3
Targeting AMPK with Irisin: Implications for metabolic disorders, cardiovascular health, and inflammatory conditions — A systematic review
Lucas Fornari Laurindo, Victória Dogani Rodrigues, Lívia Fornari Laurindo, et al.
Life Sciences (2024) Vol. 360, pp. 123230-123230
Open Access | Times Cited: 2
The Role of Organokines in Obesity and Type 2 Diabetes and Their Functions as Molecular Transducers of Nutrition and Exercise
Ji Ye Lim, Eunju Kim
Metabolites (2023) Vol. 13, Iss. 9, pp. 979-979
Open Access | Times Cited: 7
Bezafibrate Reduces Elevated Hepatic Fumarate in Insulin-Deficient Mice
András Frankó, Martin Irmler, Cornelia Prehn, et al.
Biomedicines (2022) Vol. 10, Iss. 3, pp. 616-616
Open Access | Times Cited: 9
Mechanisms and effects of AdipoRon, an adiponectin receptor agonist, on ovarian granulosa cells—a systematic review
Lucas Fornari Laurindo, Lívia Fornari Laurindo, Victória Dogani Rodrigues, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 1
Hepatokines and MASLD: The GLP1-Ras-FGF21-Fetuin-A Crosstalk as a Therapeutic Target
Ilaria Milani, Michela Codini, Gloria Guarisco, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10795-10795
Open Access | Times Cited: 1
Contribution of organokines in the development of NAFLD/NASH associated hepatocellular carcinoma
Meenakshi Vachher, Savita Bansal, Bhupender Kumar, et al.
Journal of Cellular Biochemistry (2022) Vol. 123, Iss. 10, pp. 1553-1584
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top